UBS maintains a Neutral rating on Remy Cointreau with a target price of €65, following the company's first half results for 2024-25, which showed EBIT 10% above consensus. However, the outlook suggests a potential EBIT downgrade of 8% to 17% for FY25, with anticipated organic sales declines of 15% to 18%. The group reaffirms its long-term financial targets for 2029-30, aiming for a gross margin of 72% and a current operating margin of 33%.
